Displaying 61 - 70 of 1288 Articles
Niall McGahon
Niall McGahon
30 Jan 2020

MS in the family

MS was introduced to my family in 2005 with my mother’s diagnosis. Little did we think that we would be re-introduced 10 years later to Version 2.0. MS in not a member of my family, if you would excuse the analogy, I’m the lead of my own reality show.

Trevis Gleason
23 Jan 2020

Happy New Year from MS & Me

It’s hard for us to believe, but the MS & Me blog has entered it’s seventh year in existence.  As we look forward to the New Year and some interesting takes on topics, we also acknowledge to a few of our cadre of talented writers who are off to attend to other aspects of their life.

Niamh McCarron
Niamh McCarron
19 Dec 2019

My MS Year

It’s hard to believe that another year has gone by, and that we’re going into 2020 in a couple of weeks. I have a sneaky suspicion that I am beginning to show my age when I say things like that. The last 12 months seem to have flown by, with a lot of things going on in my home and work life, as well as in the world of MS.

Teresa McShane
Teresa McShane
26 Nov 2019

MS – Balance in Body and in Life

Everyone needs to look after their general health, both body and mind, but this can be more important when you have been diagnosed with a long-term condition like multiple sclerosis. This week Teresa McShane looks at the changes she has made to achieve a balance in body and in life.

MS Ireland
23 Nov 2019

Ocrelizumab (Ocrevus) Update

MS Ireland welcome the decision made by the HSE to reimburse Ocrelizumab or Ocrevus for people living with relapsing MS, including those with relapsing forms of secondary progressive MS. We are disappointed that this decision has not been extended to those with primary progressive MS. Ocrelizumab, which is administered via intravenous infusion every 6 months, is the only medication currently licensed for those living with relapsing and primary progressive forms of MS.